Tripartite motif 32 prevents pathological cardiac hypertrophy
Open Access
- 1 April 2016
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 130 (10), 813-828
- https://doi.org/10.1042/cs20150619
Abstract
TRIM32 (tripartite motif 32) is widely accepted to be an E3 ligase that interacts with and eventually ubiquitylates multiple substrates. TRIM32 mutants have been associated with LGMD-2H (limb girdle muscular dystrophy 2H). However, whether TRIM32 is involved in cardiac hypertrophy induced by biomechanical stresses and neurohumoral mediators remains unclear. We generated mice and isolated NRCMs (neonatal rat cardiomyocytes) that overexpressed or were deficient in TRIM32 to investigate the effect of TRIM32 on AB (aortic banding) or AngII (angiotensin II)-mediated cardiac hypertrophy. Echocardiography and both pathological and molecular analyses were used to determine the extent of cardiac hypertrophy and subsequent fibrosis. Our results showed that overexpression of TRIM32 in the heart significantly alleviated the hypertrophic response induced by pressure overload, whereas TRIM32 deficiency dramatically aggravated pathological cardiac remodelling. Similar results were also found in cultured NRCMs incubated with AngII. Mechanistically, the present study suggests that TRIM32 exerts cardioprotective action by interruption of Akt- but not MAPK (mitogen-dependent protein kinase)-dependent signalling pathways. Additionally, inactivation of Akt by LY294002 offset the exacerbated hypertrophic response induced by AB in TRIM32-deficient mice. In conclusion, the present study indicates that TRIM32 plays a protective role in AB-induced pathological cardiac remodelling by blocking Akt-dependent signalling. Therefore TRIM32 could be a novel therapeutic target for the prevention of cardiac hypertrophy and heart failure.This publication has 48 references indexed in Scilit:
- Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophyThe Journal of cell biology, 2012
- AKT signalling in the failing heartEuropean Journal of Heart Failure, 2011
- The common missense mutation D489N in TRIM32 causing limb girdle muscular dystrophy 2H leads to loss of the mutated protein in knock-in mice resulting in a Trim32-null phenotypeHuman Molecular Genetics, 2011
- TRIM32 Protein Sensitizes Cells to Tumor Necrosis Factor (TNFα)-induced Apoptosis via Its RING Domain-dependent E3 Ligase Activity against X-linked Inhibitor of Apoptosis (XIAP)Online Journal of Public Health Informatics, 2011
- Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overloadProceedings of the National Academy of Sciences of the United States of America, 2010
- Regulation of the Psoriatic Chemokine CCL20 by E3 Ligases Trim32 and Piasy in KeratinocytesJournal of Investigative Dermatology, 2010
- TRIM32 is an E3 ubiquitin ligase for dysbindinHuman Molecular Genetics, 2009
- The TRIM-NHL Protein TRIM32 Activates MicroRNAs and Prevents Self-Renewal in Mouse Neural ProgenitorsCell, 2009
- Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic componentHuman Molecular Genetics, 2009
- Homozygosity mapping with SNP arrays identifiesTRIM32, an E3 ubiquitin ligase, as a Bardet–Biedl syndrome gene (BBS11)Proceedings of the National Academy of Sciences of the United States of America, 2006